Disruption of the Muscle–Brain Axis in Ageing: Role of Myokines in Sarcopenia and Neurodegeneration
Open Access
Abstract
This narrative review analyzes how myokines act as key links in communication between skeletal muscle and the brain, focusing on the impact of aging on this axis. Although the current literature links defects in this signaling pathway to sarcopenia, neurodegeneration, and cognitive decline, we still do not know exactly what role each molecule plays individually. Among the main gaps in our understanding are questions about how these substances are transported to the nervous system, what their specific receptors are, and what cause-and-effect relationship actually exists between losing muscle mass and developing neurological problems. In fact, in humans, it remains unclear whether myokines actually reach the brain in truly effective concentrations or whether their benefits are due more to peripheral metabolic, vascular, and inflammatory changes. Today, most of the mechanistic evidence comes from animal and cellular models, while observational studies predominate in humans. This is further complicated by uncertainties regarding the actual origin of these proteins in tissues, their passage through the blood–brain barrier, and their measurement in the blood, making it difficult to determine whether these proteins act as causes, consequences, or simply compensatory responses to aging and disease. On the other hand, although exercise remains the most robust tool for maintaining muscle health and protecting cognitive function, it is still unclear whether we could replicate those same benefits by isolating and stimulating specific myokines. The major challenge for the future is to develop human studies that combine standardized biomarkers with long-term monitoring of muscle function, cognition, and brain structure. Only then will we know whether this fascinating muscle–brain axis can move beyond being a promising hypothesis to become a real therapeutic target.Keywords
This publication has 85 references indexed in Scilit:
- Muscle-brain crosstalk as a driver of brain health in agingGeroScience, 2025
- Risk factors for sarcopenia in community setting across the life course: A systematic review and a meta-analysis of longitudinal studiesArchives of Gerontology and Geriatrics, 2025
- Metabolomic insight into the link of intermuscular fat with cognitive performance: the Health ABC StudyGeroScience, 2025
- Neurobiological role and therapeutic potential of exercise-induced irisin in Alzheimer's disease managementAgeing Research Reviews, 2025
- Therapeutic applications and challenges in myostatin inhibition for enhanced skeletal muscle mass and functionsMolecular and Cellular Biochemistry, 2024
- Unveiling the muscle-brain axis: A bidirectional mendelian randomization study investigating the causal relationship between sarcopenia-related traits and brain agingArchives of Gerontology and Geriatrics, 2024
- The prevalence of sarcopenia in Parkinson’s disease and related disorders- a systematic reviewNeurological Sciences, 2023
- Neuromuscular junction transmission failure in aging and sarcopenia: The nexus of the neurological and muscular systemsAgeing Research Reviews, 2023
- Promise of irisin to attenuate cognitive dysfunction in aging and Alzheimer’s diseaseAgeing Research Reviews, 2022
- Branched-chain amino acid metabolism is regulated by ERRα in primary human myotubes and is further impaired by glucose loading in type 2 diabetesDiabetologia, 2021